Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Machines: Problem Solving II01:30

Machines: Problem Solving II

731
Machines are complex structures consisting of movable, pin-connected multi-force members that work together to transmit forces. Consider a lifting tong carrying a 100 kg load. It comprises movable sections DAF and CBG linked together with member AB.
731
Machines: Problem Solving I01:22

Machines: Problem Solving I

784
A toggle clamp is a mechanical device commonly used for holding and clamping objects in various applications, such as woodworking, metalworking, and assembly operations. Consider a toggle clamp subjected to a force of 200 N at the handle. The vertical clamping force can be calculated, provided the dimensions of the toggle clamp are known.
The toggle clamp system is a machine structure consisting of movable, pin-connected multi-force members that form a stabilized system to transmit forces. The...
784
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

390
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
390
Mechanical Efficiency of Real Machines01:14

Mechanical Efficiency of Real Machines

1.4K
The mechanical efficiency of a machine is a fundamental concept that describes how effectively a machine can convert input work into output work. According to this concept, the efficiency of a machine is equal to the ratio of the output work to the input work. An ideal machine, meaning a machine that has no energy losses, has an efficiency of one. This implies that the input work and the output work are equal.
However, in reality, no machine can be truly ideal, and all of them experience some...
1.4K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

319
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
319

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.

Leukemia·2015
Same author

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Leukemia·2013
Same author

Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia.

Leukemia·2012
Same author

\4 integrin expression onin vitro andin vivo metastatic variants of lewis lung carcinoma.

Cytotechnology·2012
Same author

Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.

Leukemia·2009
Same author

Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients.

Oncogene·2009
Same journal

Deconvoluting MLL1-dependent pathways in hematopoiesis and leukemogenesis.

Leukemia supplements·2016
Same journal

New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance.

Leukemia supplements·2016
Same journal

STAT3 as a mediator of BCR-ABL1-independent resistance in chronic myeloid leukemia.

Leukemia supplements·2016
Same journal

Dissecting reprogramming, differentiation and conversion with network biology.

Leukemia supplements·2016
Same journal

Insights into the pathophysiology and therapy of myeloproliferative neoplasms from mouse models.

Leukemia supplements·2016
Same journal

Myeloid differentiation and the leukemia-initiating cell.

Leukemia supplements·2016
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

Where are we going with CML research?

D Perrotti1

  • 1Department of Microbiology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University , Columbus, OH, USA.

Leukemia Supplements
|May 14, 2016
PubMed
Summary
This summary is machine-generated.

Tyrosine kinase inhibitors (TKIs) have revolutionized chronic myelogenous leukemia (CML) treatment, leading to clinical cures for most. However, residual CML stem cells persist, necessitating research into novel therapies for a complete biological cure.

Keywords:
BCR-ABL1FTY720Janus kinase 2chronic myelogenous leukemialeukemic hematopoietic stem cellsprotein phosphatase 2A

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.6K

Related Experiment Videos

Last Updated: Mar 21, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.6K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Tyrosine kinase inhibitors (TKIs) like imatinib, dasatinib, and nilotinib have transformed chronic myelogenous leukemia (CML) treatment.
  • Most newly diagnosed CML patients respond well, achieving a clinical cure, with progression to blast crisis becoming rare.

Purpose of the Study:

  • To address the lack of curative therapy for patients who transform despite TKI treatment.
  • To investigate mechanisms of TKI-resistant CML stem cell survival and self-renewal.
  • To identify novel small molecules for selective eradication of leukemic stem cells.

Main Methods:

  • Dissection of molecular mechanisms regulating TKI-resistant CML stem cells.
  • Focus on survival and self-renewal pathways in Philadelphia-chromosome-positive cells.
  • Development of targeted small molecules.

Main Results:

  • TKIs do not eliminate CML stem cells, leaving a dormant reservoir.
  • Research is shifting towards understanding and targeting these resistant stem cells.
  • The ultimate goal is a 'biological' cure, not just a clinical one.

Conclusions:

  • Despite TKI success, a cure for CML remains elusive due to persistent leukemic stem cells.
  • Targeting CML stem cell survival and self-renewal is crucial for developing curative therapies.
  • Future research aims to develop selective agents to eradicate CML while sparing normal hematopoietic stem cells.